Business
OpenAI is in discussions to acquire a hardware startup that CEO Sam Altman has been developing with former Apple design chief Jony Ive for a potential price exceeding $500 million,
The Quiet Revolution in AI: Often Happening Behind the Scenes
AI may not soon write the next great American novel, but it’s quietly transforming the foundations of how we manage and organize the world's
Silicon Valley’s Elite Bets $34M That AI Agents Will Replace Entry-Level CPA Jobs
Basis, a New York-based startup developing autonomous AI agents for accounting firms, has raised $34 million in Series A funding to transform how accountants
The Silent Revolution of Mind Control
The rise of AI agents marks a profound shift in how power and control operate in our society. Unlike traditional forms of authority that
From Black Mirror Fright to Financial Woes: Boston Dynamics’ Robot Dog Journey
Boston Dynamics, once the pioneer of advanced robotics and creator of the infamous Spot robot dog, has found itself in a precarious position, struggling
The Dawn of AI Supremacy: OpenAI’s Operator Leads the Charge
OpenAI's Operator, launching in 2025, represents years of AI innovation and UI design. Initially aimed at simplifying tasks, it has become OpenAI's flagship product,
Elon Musk’s Wealth Soars Past $400 Billion, Marking Historic Milestone
In a stunning display of wealth accumulation, Elon Musk has become the first person in history to amass a fortune exceeding $400 billion. The Bloomberg
KAST Raises $10M to Enter Ripple’s Space in Stablecoin Neobanking
In a financial landscape where volatility and inefficiencies often plague emerging markets, KAST aims to rewrite the rules of digital banking. The stablecoin-powered neobank has announced
Europe’s AI Gamble: Will Overregulation Leave the EU in the Dust?
The European Union is making a high-stakes gamble with its stringent AI regulations, exemplified by the AI Act (Regulation (EU) 2024/1689). While the Act’s
Blood Plasma From Survivors Will Be Given to Coronavirus Patients
Coronavirus patients will receive blood plasma from individuals who have recovered from the disease. New York-based doctors will soon test the idea on hospitalized patients,